Sign Up Today and Learn More About Pulmocide Stock
Invest in or calculate the value of your shares in Pulmocide or other pre-IPO companies through EquityZen's platform.
Pulmocide Stock (PULM)
Pulmocide is focused on the development of inhaled medicines for the treatment of viral and fungal infections of the respiratory tract.
About Pulmocide Stock
Founded
2013
Industries
Messaging and Telecommunications, Content and Publishing, Sports
Pulmocide Press Mentions
Stay in the know about the latest news on Pulmocide
Polymorphs of the triazole antifungal compound pc945
patents • Feb 08, 2025
Pulmocide Announces Presentation at 43rd Annual J.P. Morgan Healthcare Conference
globenewswire • Jan 10, 2025
Pulmocide Announces Successful Results from the OPERA-S Study: a Phase 2 Safety Study with Inhaled Opelconazole
finance • Jun 25, 2024
Pulmocide Announces Successful Results from the OPERA-S Study: a Phase 2 Safety Study with Inhaled Opelconazole
globenewswire • May 24, 2024
Pulmocide exits OPERA with phase 2 evidence of antifungal safety and efficacy
fiercebiotech • Apr 20, 2024
Pulmocide Management
Leadership team at Pulmocide
Board Member
Kate Bingham
Chairman and Chief Executive Officer
Dan Burgess
Join now and verify your accreditation status to gain access to:
- Pulmocide Current Valuation
- Pulmocide Stock Price
- Pulmocide Management
- Available deals in Pulmocide and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Pulmocide Cap Table and Funding History by Share Class and Liquidity Preferences
- Pulmocide Revenue and Financials
- Pulmocide Highlights
- Pulmocide Business Model
- Pulmocide Risk Factors
- Pulmocide Research Report from SACRA Research
Trading Pulmocide Stock
How to invest in Pulmocide stock?
Accredited investors can buy pre-IPO stock in companies like Pulmocide through EquityZen funds. These investments are made available by existing Pulmocide shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Pulmocide stock?
Shareholders can sell their Pulmocide stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
